President ' ’s $ 215 million investment in the Precision Medicine Initiative illustrates the emphasis placed on personalising care in the fight against cancer . Most recently the increase in targeted therapies , using kinase ##s and monoclonal antibodies , has allowed for therapy personalisation in an increasing numbers of cancer patients . Despite this , curative treatments for advanced malignant tumours are uncommon .
President Obama’s $215m investment in the Precision Medicine Initiative illustrates the emphasis placed on personalising care in the fight against cancer. Most recently the advances in targeted therapies, using kinase inhibitors and monoclonal antibodies, has allowed for therapy personalisation in an increasing numbers of cancer patients. Despite progress, curative interventions for advanced malignant tumours are uncommon.